D03.1
Melanoma in situ of eyelid, including canthus
Clinical Classification Guidelines
Medical Intelligence & Overview
Melanoma in situ of the eyelid, classified under ICD-10 code D03.1, is a type of skin cancer that is confined to the outermost layer of skin (the epidermis) and has not yet invaded deeper tissues. It specifically affects the eyelids, including the canthus (the corners where the eyelids meet). This condition is considered the earliest form of melanoma and is highly treatable when diagnosed early. Recognizing the signs and seeking prompt medical attention can significantly improve outcomes.
Causes & Symptoms
Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds Genetic predispositions that increase susceptibility to skin cancers History of sunburns, especially during childhood Fair skin, light hair, and light eye color, which are more vulnerable to UV damage Presence of numerous or atypical moles on the skin around the eyes Immunosuppression due to medical conditions or medications
Key Symptoms: A new or changing dark spot or pigmentation on the eyelid A flat, slightly elevated, or irregularly shaped lesion with uneven borders Color variations within the lesion, such as black, brown, or even shades of red and blue Persistent or non-healing ulcer or sore on the eyelid A lesion that increases in size over time Discoloration or thickening of the eyelid skin Sensitivity or irritation in the affected area
Diagnostic & Treatment
Diagnosis Path: - Histopathological analysis to determine the specific characteristics and extent of the lesion
Treatment Protocols: - Close follow-up examinations to monitor for any recurrence or new lesions
Clinical Advice & FAQs
Billing Guidance
Is D03.1 a billable ICD-10 code?
Yes, D03.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D03.1?
Clinical documentation must specify the nature of Melanoma in situ of eyelid, including canthus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
